Precision Medicine in Thoracic Oncology: Targeted Therapies and Personalized Treatment Strategies
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 59
Special Issue Editor
Interests: lung neoplasm; thymic tumors; mediastinum; thoracic cancer treatments; surgery; non-small cell lung cancer; minimally invasive surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Thoracic malignancies have a huge impact on patients and their families, requiring the beginning of a challenging route for physicians to individuate the appropriate treatment strategy.
The recent increase in knowledge about cancer biology and the possibility of identifying target therapies or immunotherapies in this setting will improve the survival rate in these cases.
However, identifying the best therapeutic strategy combining different specialties such as surgeons, medical oncologists, and radiotherapists is still evolving, considering the possibility of planning tailored therapies based on patient characteristics, stage, and tumor biology.
This Special Issue will highlight the recent advances and possibilities in thoracic oncology, focusing on tumor biology and possible therapeutic approaches integrating the different sub-specialties.
We invite the submission of the following types of manuscripts: original research articles, meta-analyses, systematic reviews, review articles, method articles, perspective articles, and technology reports.
Dr. Marco Chiappetta
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thoracic oncology
- thoracic tumors
- translational research
- target therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
